Skip to content

Effect of Bupivacaine Liposome Used for Adductor Canal Block (ACB) + Infiltration between the Popliteus and the Capsule of the Knee (IPACK) Block on Postoperative Pain and Accelerated Rehabilitation after Total Knee Arthroplasty: A Single-center, Prospective, Double-blind, Randomized Controlled Trial

Effect of Bupivacaine Liposome Used for Adductor Canal Block (ACB) + Infiltration between the Popliteus and the Capsule of the Knee (IPACK) Block on Postoperative Pain and Accelerated Rehabilitation after Total Knee Arthroplasty: A Single-center, Prospective, Double-blind, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111100
Enrollment
Unknown
Registered
2025-10-26
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee joint diseases

Interventions

Sponsors

Fuyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing primary unilateral total knee arthroplasty (TKA); 2. Age ranging from 40 to 80 years; 3. American Society of Anesthesiologists (ASA) physical status classification of grades ? to ?.

Exclusion criteria

Exclusion criteria: 1. Patients with failure of vital organs such as heart and lung; 2.Abnormal liver or kidney function (ALT/AST > 1.5 times the normal value, blood urea nitrogen (BUN) > 8.3 mmol/L, serum creatinine (Scr) > 115 µmol/L); 3. Diabetic patients with poor glycemic control and judged by the researcher to have infection risk; 4. Combined with disturbance of consciousness or mental disorders; 5. History of open knee surgery; 6. Neuromuscular dysfunction affecting lower limb function; 7. Allergy to drugs used in this study; 8. Opioid addiction; 9. Language barriers or inability to complete the Visual Analogue Scale (VAS) for pain assessment; 10. Patients deemed unsuitable for participation by the researcher due to other reasons.

Design outcomes

Primary

MeasureTime frame
Total postoperative sufentanil dosage;

Secondary

MeasureTime frame
Postoperative VAS pain scores at rest and during movement;Postoperative recovery quality;Postoperative incidence of chronic pain;Adverse reaction;Time of first use of analgesics after surgery;PCIA effective compression frequency;

Countries

China

Contacts

Public ContactWenmeng Han

Fuyang People's Hospital

527712458@qq.com+86 189 5589 5595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026